Filing Details
- Accession Number:
- 0001209191-21-066004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-22 07:30:39
- Reporting Period:
- 2021-11-18
- Accepted Time:
- 2021-11-22 07:30:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1579428 | Axsome Therapeutics Inc. | AXSM | Pharmaceutical Preparations (2834) | 454241907 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1658379 | Mark Coleman | C/O Axsome Therapeutics, Inc. 22 Cortlandt Street, 16Th Floor New York NY 10007 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-18 | 409 | $35.07 | 421,407 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2021-11-18 | 1,021 | $35.10 | 422,428 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,100 | Direct |
Footnotes
- Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
- Represents additional shares held directly by the reporting person prior to November 18, 2021.
Billionaire Hedge Funds
